Invention Grant
- Patent Title: Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor
-
Application No.: US16651238Application Date: 2018-11-28
-
Publication No.: US11266619B2Publication Date: 2022-03-08
- Inventor: Tohru Tanaka , Hidenori Ito , Ko Rii
- Applicant: SBI Pharmaceuticals Co., Ltd. , National Center for Child Health and Development
- Applicant Address: JP Tokyo; JP Tokyo
- Assignee: SBI Pharmaceuticals Co., Ltd.,National Center for Child Health and Development
- Current Assignee: SBI Pharmaceuticals Co., Ltd.,National Center for Child Health and Development
- Current Assignee Address: JP Tokyo; JP Tokyo
- Agency: Myers Bigel, P.A.
- Priority: JPJP2017-231449 20171201
- International Application: PCT/JP2018/043704 WO 20181128
- International Announcement: WO2019/107389 WO 20190606
- Main IPC: A61K31/197
- IPC: A61K31/197 ; C07K16/28 ; A61K33/26 ; A61K33/24 ; A61K33/30 ; A61K38/00
Abstract:
The object of the invention is to provide a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor. Provided is a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor comprising 5-aminolevulinic acids (ALAs) as the active ingredient.
Public/Granted literature
- US20200297674A1 PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTITUMOR EFFECT BY IMMUNE CHECKPOINT INHIBITOR Public/Granted day:2020-09-24
Information query
IPC分类:
